Clinical trial
A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration
NCT00187525 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00187525 |
|---|---|
| Title | A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | Forest Laboratories Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Frontotemporal Lobar Degeneration |
| Intervention type | Drug |
| Interventions | Memantine |
| Start date | May 1, 2004 |
| Primary completion | Oct 1, 2005 |
| Completion | Oct 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Nov 12, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: